Lv2
170 积分 2021-01-20 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
4天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
5天前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
5天前
已完结
Staphylococcus aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell–derived Cytokines
18天前
已关闭
Emerging pharmacotherapies in chronic rhinosinusitis with nasal polyps
1个月前
已完结
The nose knows: Olfaction as a metabolic gatekeeper in health and disease
8个月前
已完结
皖公网安备34019202002308
